Clinical Trial Update: A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating golimumab in Indian participants with active ankylosing spondylitis or psoriatic arthritis has completed. Results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Johnson & Johnson Private Limited | Conditions: Spondylitis, Ankylosing, Arthritis, Psoriatic | Phase 4 | Status: COMPLETED | Results posted: 2023-01-20